Survival after Operations for Colorectal Cancer in Patients aged 75 Years or over
Objective: To define factors that predict mortality and survival in patients with colorectal cancer who are aged 75 or over. Design: Retrospective study. Setting: University hospital, Finland. Subjects: 231 patients aged 75 or over who were admitted to hospital with colorectal cancer during the 14-y...
Gespeichert in:
Veröffentlicht in: | The European journal of surgery 2000-07, Vol.166 (6), p.473-479 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Objective: To define factors that predict mortality and survival in patients with colorectal cancer who are aged 75 or over. Design: Retrospective study. Setting: University hospital, Finland. Subjects: 231 patients aged 75 or over who were admitted to hospital with colorectal cancer during the 14-year period 1980-93. Main outcome measures: Morbidity, mortality, recurrence, and survival. Results: In-hospital mortality after any kind of operation was 8/211 (4%), and 8/175 (5%) of those who had their tumours resected. Morbidity was 35/175 (20%). Factors associated with mortality were weight loss, Dukes'stage, extent of resection, and type of operation. Overall 5-year survival was 28%, overall 10-year survival was 4%, and median survival was 33 months (range 0-150). Survival was most closely related to Duke's stage, extent of resection, and recurrent disease on univariate analysis, but multivariate analysis identified only mode of recurrence (p < 0.0001), recurrent disease (p < 0.004), and extent of resection (p < 0.009) as independent predictors of survival. The recurrence rate after radical resection was 49/141 (35%) and the median disease-free interval was 10 months (range 4-64). Mortality after resection for recurrent cancer was 3/17 (18%) and morbidity 5/17 (29%). Conclusion: Age alone is not a risk factor for postoperative mortality or a predictor of long-term survival. Low mortality and acceptable long-term survival can be achieved in patients aged 75 or over if those with extensive distant metastases, and those whose general condition is too poor to stand a major operation, are treated conservatively. |
---|---|
ISSN: | 1102-4151 1741-9271 |
DOI: | 10.3109/110241500750008790 |